Back to resources

Thought Leadership Expertise

Publications

Straight From the Horse’s Mouth

Regulatory Roundup

Blake Bergam and Sara Mills on FDA's Guidance on Human- and Animal-Derived Materials in CGT

Via Insights Bio: "Challenges and benefits in harnessing platform processes for viral vector manufacture"

"FDA's CBER Issues Final Guidance For CAR-T Cell Products" by Anne Lamontagne and Wendy Liang

Brent Morse and Nate Manley on "FDA's Updated Guidance On Human Genome Editing"

Brent Morse and Amanda Mack on "Considerations for development of gene-edited PSC-based therapies"

Cell and Gene Collaborative's COGs: Words Of Wisdom To ‘Keep The End In Mind'

Cell and Gene Collaborative's COGs: Progress & Pitfalls In Our Quest For Affordability

CEO Anthony Davies on "Gottlieb's math"

DHC white paper: Beyond Empty and Full: Understanding Heterogeneity in rAAV Products and Impurities

Join the Quarter Horse Newsletter

We’ll send you a quarterly newsletter all things DHC!

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.